PharmAust affirms strategy with name change to Neurizon Therapeutic
15 Oct 2024 //
PR NEWSWIRE
PharmAust announces positive Phase 1 MEND Study Top-Line Results in MND / ALS
28 Feb 2024 //
PR NEWSWIRE
15 Oct 2024 //
PR NEWSWIRE
28 Feb 2024 //
PR NEWSWIRE